 |
 |
 |
|
DoxyPEP Eligibility, Use, and Potential for STI Reduction in a Large HIV Cohort in Washington, DC...."early uptake of DoxyPEP was minimal, yet a majority of PWH were DoxyPEP eligible"
|
|
|
CROI 2025 SF March 9-12
Amanda D. Castel, MD, MPH
DC Cohort Study, Principal Investigator
Professor, Department of Epidemiology
The George Washington University Milken Institute School of Public Health










|
|
|
 |
 |
|
|